PTGS2 and lung carcinoma: Mice given 9cRA supplementation exhibited significantly decreased tumor multiplicity and a trend toward lower tumor incidence, implying that 9cRA may protect against lung cancer, with this effect mediated in part by 9cRA activation of RARβ but not COX2 transcription suppression [246].